The global bronchoscopes market size was valued at USD 1.14 billion in 2023 and is projected to grow at a CAGR of 11.4% from 2024 to 2030. The rising incidences of respiratory disorders and growing awareness about early diagnosis are driving demand for bronchoscopes. Bronchoscopes are primarily used for the assessment and management of multiple respiratory and airway diseases. Conditions such as blockages, chronic obstructive pulmonary diseases (COPD), bronchopulmonary hemorrhage, tumors, airway stenosis, and inflammatory conditions can be detected and diagnosed through these devices.
The increasing incidence of respiratory conditions such as COPD, asthma, lung cancer, and emphysema worldwide are significant drivers for the bronchoscopy market. The World Health Organization (WHO) reports that COPD is the third leading cause of death worldwide, that led to 3.23 million deaths in 2019, with projections indicating it could become a major health threat by 2030. As the global population ages and environmental pollution worsens, the incidence of these conditions is expected to rise, with one in seven older adults suffering from lung conditions. This is expected to propel the demand for bronchoscopy procedures for diagnosis and treatment.
The field of bronchoscopy is evolving, with advancements in technology leading to the development of more precise, efficient, and safer bronchoscopes. For instance, recent innovations include virtual bronchoscopy, which utilizes 3D imaging to provide a more detailed view of the airways, and robotic bronchoscopes that offer improved maneuverability and control during procedures.
粤公网安备44000000000000号
